Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutamic Acid | 7 | 2020 | 1169 | 1.090 |
Why?
|
| Hyperglycemia | 2 | 2022 | 1373 | 0.840 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2020 | 3336 | 0.750 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 415 | 0.660 |
Why?
|
| Gyrus Cinguli | 3 | 2022 | 1091 | 0.630 |
Why?
|
| Hypoglycemia | 3 | 2015 | 861 | 0.600 |
Why?
|
| Prediabetic State | 1 | 2019 | 499 | 0.470 |
Why?
|
| Fluvoxamine | 2 | 2004 | 74 | 0.430 |
Why?
|
| Basal Ganglia | 1 | 2015 | 546 | 0.420 |
Why?
|
| Magnetic Resonance Spectroscopy | 12 | 2019 | 3760 | 0.420 |
Why?
|
| Motor Cortex | 1 | 2019 | 986 | 0.400 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 1422 | 0.380 |
Why?
|
| Inositol | 3 | 2022 | 218 | 0.370 |
Why?
|
| Brain | 16 | 2021 | 26385 | 0.320 |
Why?
|
| Fluoxetine | 2 | 2004 | 749 | 0.320 |
Why?
|
| Prefrontal Cortex | 3 | 2021 | 2147 | 0.320 |
Why?
|
| Executive Function | 2 | 2017 | 1364 | 0.300 |
Why?
|
| Glutamine | 5 | 2019 | 578 | 0.280 |
Why?
|
| Nerve Net | 2 | 2015 | 2174 | 0.270 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 975 | 0.250 |
Why?
|
| Phosphocreatine | 4 | 2019 | 269 | 0.240 |
Why?
|
| Aspartic Acid | 5 | 2019 | 576 | 0.230 |
Why?
|
| Schizophrenia | 6 | 2021 | 6882 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2019 | 11725 | 0.220 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 5708 | 0.220 |
Why?
|
| Alcohol Deterrents | 2 | 1998 | 39 | 0.200 |
Why?
|
| Taurine | 2 | 1998 | 94 | 0.190 |
Why?
|
| Migraine Disorders | 2 | 2023 | 1620 | 0.190 |
Why?
|
| Blood Glucose | 4 | 2022 | 6256 | 0.180 |
Why?
|
| Video Games | 2 | 2014 | 184 | 0.180 |
Why?
|
| Creatine | 2 | 2019 | 421 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2023 | 35421 | 0.180 |
Why?
|
| Glycerylphosphorylcholine | 1 | 2019 | 25 | 0.180 |
Why?
|
| Glucose | 3 | 2022 | 4397 | 0.170 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2019 | 126 | 0.170 |
Why?
|
| Protons | 3 | 2013 | 1127 | 0.170 |
Why?
|
| Phosphorylcholine | 1 | 2019 | 162 | 0.170 |
Why?
|
| Lateral Ventricles | 1 | 2019 | 146 | 0.160 |
Why?
|
| Theta Rhythm | 1 | 2019 | 207 | 0.150 |
Why?
|
| Glutathione | 1 | 2019 | 589 | 0.140 |
Why?
|
| Antipsychotic Agents | 3 | 2021 | 3057 | 0.130 |
Why?
|
| Bipolar Disorder | 3 | 2020 | 5027 | 0.130 |
Why?
|
| Thalamus | 3 | 2017 | 1023 | 0.130 |
Why?
|
| Brain Mapping | 5 | 2021 | 6669 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 577 | 0.130 |
Why?
|
| Young Adult | 9 | 2022 | 56430 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1081 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 1178 | 0.120 |
Why?
|
| Epilepsy | 2 | 2023 | 3310 | 0.120 |
Why?
|
| Alcoholism | 3 | 2014 | 1906 | 0.120 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2021 | 1432 | 0.110 |
Why?
|
| Male | 30 | 2022 | 350118 | 0.110 |
Why?
|
| Adult | 22 | 2022 | 214055 | 0.110 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 3046 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2013 | 1121 | 0.110 |
Why?
|
| Cerebrum | 1 | 2013 | 137 | 0.110 |
Why?
|
| Haloperidol | 1 | 2013 | 397 | 0.100 |
Why?
|
| Fluorine Radioisotopes | 3 | 2006 | 442 | 0.100 |
Why?
|
| Prosencephalon | 1 | 2013 | 303 | 0.100 |
Why?
|
| Middle Aged | 18 | 2020 | 213383 | 0.100 |
Why?
|
| Depressive Disorder, Major | 3 | 2008 | 4644 | 0.090 |
Why?
|
| Female | 24 | 2022 | 380194 | 0.090 |
Why?
|
| Spin Labels | 2 | 2023 | 332 | 0.090 |
Why?
|
| Internet | 2 | 2014 | 3064 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2013 | 1572 | 0.090 |
Why?
|
| Amygdala | 1 | 2017 | 1315 | 0.090 |
Why?
|
| Acute Disease | 1 | 2020 | 7149 | 0.090 |
Why?
|
| Humans | 35 | 2023 | 744343 | 0.080 |
Why?
|
| Hippocampus | 3 | 2017 | 3675 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 462 | 0.080 |
Why?
|
| Antifungal Agents | 1 | 2013 | 730 | 0.080 |
Why?
|
| Multifactorial Inheritance | 1 | 2016 | 1194 | 0.080 |
Why?
|
| Emotions | 1 | 2020 | 2661 | 0.080 |
Why?
|
| Family Health | 1 | 2013 | 1282 | 0.080 |
Why?
|
| Uridine | 1 | 2008 | 146 | 0.080 |
Why?
|
| Triazoles | 1 | 2013 | 911 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3864 | 0.080 |
Why?
|
| Insulin | 1 | 2022 | 6580 | 0.070 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2007 | 65 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2014 | 1534 | 0.070 |
Why?
|
| Fluorine Compounds | 1 | 2006 | 5 | 0.070 |
Why?
|
| Neural Pathways | 4 | 2021 | 2972 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.070 |
Why?
|
| Triiodothyronine | 1 | 2008 | 494 | 0.070 |
Why?
|
| Astrocytes | 1 | 2013 | 1270 | 0.070 |
Why?
|
| Occipital Lobe | 1 | 2007 | 379 | 0.070 |
Why?
|
| Headache | 2 | 2023 | 1226 | 0.070 |
Why?
|
| Anti-Allergic Agents | 1 | 2006 | 141 | 0.060 |
Why?
|
| Cognition Disorders | 3 | 2014 | 4043 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2008 | 981 | 0.060 |
Why?
|
| Receptors, GABA-A | 1 | 2008 | 627 | 0.060 |
Why?
|
| Alleles | 2 | 2019 | 6933 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 2557 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2023 | 2731 | 0.050 |
Why?
|
| Eating | 1 | 2008 | 1536 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 2942 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 2006 | 850 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 503 | 0.050 |
Why?
|
| Aging | 1 | 2019 | 8664 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21746 | 0.050 |
Why?
|
| Cerebellum | 2 | 2021 | 1488 | 0.040 |
Why?
|
| Algorithms | 2 | 2023 | 13881 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2014 | 6150 | 0.040 |
Why?
|
| Antidepressive Agents | 2 | 2008 | 2838 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1602 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17446 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2899 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 6473 | 0.030 |
Why?
|
| Dipeptides | 1 | 1998 | 409 | 0.030 |
Why?
|
| Nucleus Accumbens | 1 | 1998 | 366 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 3966 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2021 | 1221 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2008 | 3748 | 0.030 |
Why?
|
| Aged | 4 | 2019 | 163280 | 0.030 |
Why?
|
| Frontal Lobe | 2 | 2012 | 1406 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.030 |
Why?
|
| Anisotropy | 1 | 2017 | 1265 | 0.030 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 6993 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2004 | 2948 | 0.030 |
Why?
|
| Myocardium | 1 | 2006 | 4776 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 1998 | 2029 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 2252 | 0.030 |
Why?
|
| Affect | 1 | 2019 | 1476 | 0.030 |
Why?
|
| Homeostasis | 2 | 2013 | 3340 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 4258 | 0.020 |
Why?
|
| Liver | 1 | 2006 | 7474 | 0.020 |
Why?
|
| Genotype | 2 | 2019 | 12951 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 4042 | 0.020 |
Why?
|
| Depression | 1 | 2009 | 7766 | 0.020 |
Why?
|
| Muscles | 1 | 2014 | 1614 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1654 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 63114 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 12261 | 0.020 |
Why?
|
| Time Factors | 2 | 2013 | 40075 | 0.020 |
Why?
|
| Memory | 1 | 2017 | 2174 | 0.020 |
Why?
|
| Cognition | 2 | 2017 | 6770 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 1017 | 0.020 |
Why?
|
| Acetates | 1 | 2008 | 311 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 25043 | 0.020 |
Why?
|
| Attention | 1 | 2017 | 2400 | 0.020 |
Why?
|
| Amphetamines | 1 | 2007 | 148 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 8949 | 0.020 |
Why?
|
| Cues | 1 | 2011 | 873 | 0.020 |
Why?
|
| Artifacts | 1 | 2014 | 1904 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2011 | 838 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 3913 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15519 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
| Half-Life | 1 | 2006 | 661 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3147 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2008 | 1030 | 0.020 |
Why?
|
| Self Report | 1 | 2016 | 3558 | 0.020 |
Why?
|
| Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
| Magnesium | 1 | 2008 | 813 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2012 | 1670 | 0.020 |
Why?
|
| Adolescent | 4 | 2017 | 85781 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6365 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2008 | 849 | 0.010 |
Why?
|
| Hallucinogens | 1 | 2007 | 180 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1998 | 12026 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1785 | 0.010 |
Why?
|
| Risk | 1 | 2016 | 9687 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2305 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2023 | 53288 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19905 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2008 | 1063 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 8301 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2327 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 2006 | 659 | 0.010 |
Why?
|
| Cocaine | 1 | 2007 | 1007 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 2025 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 3912 | 0.010 |
Why?
|
| Rats | 2 | 2013 | 24260 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
| Cannabis | 1 | 2007 | 439 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3420 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2008 | 6038 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6489 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 4669 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 7023 | 0.010 |
Why?
|
| Alanine | 1 | 1998 | 572 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9583 | 0.010 |
Why?
|
| Mitochondria | 1 | 2008 | 3520 | 0.010 |
Why?
|
| Arginine | 1 | 1998 | 944 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 1901 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 3674 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 18370 | 0.010 |
Why?
|
| Animals | 3 | 2013 | 168757 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72290 | 0.010 |
Why?
|
| Child | 1 | 2017 | 77709 | 0.010 |
Why?
|
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_